1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine

Term ID

CHEBI:73873

Synonyms

(2R)-3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate
1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine
1-Docosahexaenoyl-glycero-3-phosphocholine
LPC 22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0
LPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
Lyso(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
LysoPC 22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0
lysophosphatidylcholine(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)

Definition

A lysophosphatidylcholine 22:6 in which the remaining acyl group is (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: 1-docosahexaenoyl-sn-glycero-3-phosphocholine

1-docosahexaenoyl-sn-glycero-3-phosphocholine Show first 5 Terms
has_functional_parent: all-cis-docosa-4,7,10,13,16,19-hexaenoic acid

all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Show first 5 Terms
has_role: human metabolite mouse metabolite

human metabolite mouse metabolite Show first 5 Terms

Phenotype

Phenotype resulting from 1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine

Phenotype where environments contain 1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine

Phenotype modified by environments containing 1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine

Human Disease Model